[21] When treated with cyanocobalamin, patients with Leber's disease may develop serious optic atrophy, possibly leading to blindness, based on few case reports
( ) , CelaCor is the result of years of research, scientific validation, and clinical evaluation
Healthcare providers will usually do blood tests to check for B12 deficiency in people who have a high risk of developing it
Compared to GLP-1 Agonists: Weight management peptides like semaglutide and tirzepatide have demonstrated weight loss efficacy superior to AOD-9604 in clinical trials, but they also have distinct side effect profiles
Hair thinning Some GLP-1 users report hair thinning during aggressive weight loss phases
Because it acts on both GLP-1 and GIP receptors, it tends to produce greater weight loss, often up to 20% of body weight